Ignite Creation Date:
2024-05-06 @ 3:42 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02357615
Status:
UNKNOWN
Last Update Posted:
2015-02-06
First Post:
2015-01-30
Brief Title:
Efficacy Study of Nifedipine Controlled-Release Tablets Xin Ran to Treat Early Morning Blood Pressure and Central Arterial Pressure
Sponsor:
Shanghai Shyndec Pharmaceutical Co Ltd
Organization:
Shanghai Shyndec Pharmaceutical Co Ltd
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2014-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare nifedipine controlled-release CR tablets Xin Ran with nifedipine controlled-release tablets Adalatin the treatment of Early Morning Blood Pressure and Central Arterial Pressure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None